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1. INTRODUCTION
The zebrafish Danio rerio, a tropical freshwater fish, belongs to the family of cyprinidae, which in
the last 30 years has developed into a very popular model organism for studies of embryonic
development and human diseases. Initially the zebrafish species has been selected on the basis of
its small size of approximately 3–5 cm, its transparency during development and its high fertility,
qualities first identified by George Stresinger, the founding father of zebrafish research.1 The ability
to house thousands of small fishes and the ease of screening mutations in the translucent embryos
made it feasible to perform large-scale forward genetic screens in a vertebrate model organism. The
abundance of eggs obtained, approximately 200 eggs per female per week, is ideal for genetic and
statistical analysis. The mutagenesis screens performed in the early 1990s have led to the
identification of genes important in vertebrate organogenesis in an unbiased fashion.2,3 Many of the
isolated mutants have now been fully characterized and the mutated genes mapped, as the
zebrafish genome sequencing completes. The knowledge derived has led to a better understanding
of the underlying genetic networks governing vertebrate development. More sophisticated
phenotype-based screens have since been developed to screen for mutations in defined biological
processes.4
The development of the zebrafish is very fast and by 24 hours post fertilization (hpf), the fertilized
egg has developed into an embryo that has established most organ primordia including the nervous
system and a contracting heart tube. This is followed by the commencement of blood circulation.
The embryo hatches after about 2 days post fertilization (dpf) and reaches the larval stage at 3 dpf
when most internal organs have matured. At 30 dpf, the zebrafish metamorphose and after 90 days
has reached adulthood.
Zebrafish are easily maintained and are relatively economical in comparison to mammalian species.
About 5 adult fishes are kept in 1 liter and therefore a small laboratory aquarium facility can easily
house more than 1000 animals. Non-invasive imaging can follow the entire phase of embryonic
development while the embryo is kept in a petri dish, which allows cell biology to be performed
in an intact organism.5,6 In fact, by introducing pigments and scale mutations that renders the fish
transparent, tumors formation can be visualized and thus enable transplantation experiments to
be performed in adult zebrafish.7 The small size of the embryo allows it to be placed into 384 well
plates for small molecule screenings.8 There are however also drawbacks that restrict the utility of
the zebrafish. These include the currently limited biological resources for this model organism in
comparison to the mouse. For example antibodies used in mammals often do not cross-react in the
zebrafish limiting the utilization of this model organism for protein biochemistry. Likewise during
teleost evolution, genome duplication took place,9 which resulted in the presence of many duplicated
genes. On one hand, this complicates genetic analysis but it allows the examination of multiple
functions of a gene in separate mutants since the duplicated genes display subfunctionalization.10
The lack of embryonic stem cells, which is required for reverse genetic approaches such as the
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generation of knockout strains, has hampered the progress to utilize this organism in
biomedical research. Nonetheless, recent technological advances have greatly improved
this situation.11– 13
In this review, we will outline the knowledge of cardiac development in the zebrafish. Moreover, the
current state of knowledge in studying development and function of the cardiac conduction system in
zebrafish will be discussed. The zebrafish as a novel disease model in cardiac hypertrophy and heart
failure will be introduced. We will also discuss the role of the zebrafish as a premier model to study
cardiac regeneration. Since no single review is able to cover all aspects of this rapidly growing field, the
reader is also referred to some other excellent reviews in the field, which have been recently
published.14–17
2. HEART DEVELOPMENT
Apart from sharing well-conserved genetic pathways that govern heart formation, zebrafish heart
development proceeds through very similar steps as amniotes, and begins with the specification
of precardiac cells in the anterior lateral plate mesoderm followed by fusion of the bilateral heart
fields at the embryonic midline (Table 1). The mechanism of this seemingly simple morphogenetic
event at the very early stages of embryonic development became better understood largely due to
the powerful genetic amenability and high-resolution bioimaging of zebrafish embryos as
illustrated below.18–20
In the zebrafish, cardiac progenitors are specified as early as 5 hpf,21 just before gastrulation, a
developmental phase lasting nearly 5 hours, which results in the formation of the three primary germ
layers: ectoderm, mesoderm and the endoderm. Fusion of the bilateral heart fields by 16 hpf produces
a cardiac cone, which expresses cardiac differentiation markers such as the sarcomeric genes
tropomyosin and troponin.22 The cardiac cone then extends anteriorly and is gradually remodeled into
a primitive heart tube.
By 24 hpf, the early heart tube consists of an outer myocardial and an inner endocardial layer
separated by extracellular matrix, known as the “cardiac jelly”. Shortly after its formation, the linear
heart tube is capable of contracting rhythmically in a peristaltic manner with a conduction velocity of
1mms21.23
The heart tube loops at 33 hpf, into an S-shaped configuration, displacing the ventricle to the right of
the atrium. The transition from slow peristaltic wave to sequential chamber contraction by 36 hpf
suggests the onset of cardiac conduction system (CCS) function.
Fate mapping studies have shown that chamber identities are established as early as 5 hpf,21
attributing to differential gene expression that governs later differences in size, morphology and
contractile properties conferred by different sets of sarcomeric proteins (atrial myosin heavy chain,
amhc, in the atrium versus ventricular myosin heavy chain, vmhc, in the ventricle). By 2 dpf, the
ventricular chamber balloons into a natriuretic peptide precursor A (nppa) –labeled outer curvature
(OC) and an inner curvature (IC), which forms the future apex and base of the mature heart respectively.
Myocardial cells of the OC are elongated, bigger and conduct electrical activity thrice faster than cells
located at the IC.23,24
Table 1. Milestones of early heart development shared by different organisms. (modified from57).
Cardiac Events Human Mouse Zebrafish
Migration of precardiac
cells from epiblast
15–16 days 7 dpc (primitive streak) 50% epiboly (5.5 hpf)
First evident assembly
of myocardial plate
18 days 7 dpc (late primitive streak) 8–10 somites (,13 hpf)
Generation of single
heart tube initiated
22 days (4–10 somites) 8 dpc (5–10 somites) 20 somites (,19 hpf)
Tubular heart starts
contraction
23 days 8.5 dpc (8–10 somites) 26 somites (22 hpf)
Looping 23 days 8.5 dpc 33 hpf
Endocardial
cushions form
28 days (30–38 somites) 9.5 dpc 48 hpf
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2.1. Heart muscle growth
As the heart develops, the atrium remains a thin layer of myocardial cells whereas the ventricle
thickens to form trabeculae (myocardial projections), which are necessary to generate sufficient
contractile force to propel circulation in the growing embryo. At the same time myofibrillogenesis is
completed whereby thin and thick filaments, M line, and Z discs are assembled into uniform arrays of
cardiac sarcomeres.25 Studies in mice have shown that trabeculation of the ventricular myocardium is
dependent on endocardial-derived signals such as neuregulin, BMP10, and Brg1 (a chromatin
remodeling protein) as well as a supportive microenvironment provided by the cardiac jelly.26–29 The
requirement for the neuregulin signaling pathway in trabeculation is resonated in the zebrafish where
embryos mutated in erbB2 encoding the neuregulin receptor fail to undergo trabeculation and hence
show aberrant electrical conduction in the ventricular myocardium.30
Starting with 150 cardiac myocytes at 24 hpf, the cell number has doubled at 3 dpf. However the
embryonic heart does not rely on cell proliferation, which is negligible at this stage in development.
Addition of cells at both arterial and venous poles of the heart followed by waves of cardiac myocyte
differentiation is found to be the major mechanism for increasing cell numbers.31
The adult zebrafish heart grows to a size with a ventricular length of 1mm or larger, its atrium is lined
internally with pectinate muscle and the ventricle consists of a compact layer enveloping the inner
trabeculae, which in contrast to the mammalian heart persists into adulthood (Fig. 1). To investigate the
complexity of ventricular wall formation, Gupta and Poss recently employed a highly sophisticated
multicolor lineage tracing tool, termed Brainbow, which allows after modification and optimization of
the technique, to label approximately 20 cardiac myocytes with different colors at embryonic stage and
to trace their descendants in the adult heart.32 These experiments not only uncovered an “inside-out”
mechanism for the formation of the outer compact layer of the heart where the source of surface
myocardium originates from inner muscle fibers, but also has led to the identification of the amazing
properties of a few ‘clonally dominant’ cardiac myocytes, which display proliferative ability in a stem
cell-like manner to give rise to the entire heart wall. Hence, further investigation into the properties of
this specific cardiac myocyte population, in particular its expression profile, which underlies its unique
abilities, is necessary and may provide an insight to rebuild the damaged heart.
2.2. Endocardium and valves
Cardiac valves in the form of leaflets develop between the chambers to ensure unidirectional blood
flow.33,34 Valve formation is initiated by the restriction of bmp4, tbx2b, and vcana expression to the AV
myocardium at 37 hpf35,36 followed by the endocardial expression of notch1b, has2 and neuregulin.37,38
These changes in gene expression are accompanied by changes in endocardial cell morphology. The
endocardial cells are initially cuboidal in shape and by 72 hpf form primitive valve leaflets, which serve
to block retrograde blood flow.34 In zebrafish, the process of valve maturation, which also involves
Figure 1. Anatomy of the adult zebrafish heart. (A) Schematic representation of the adult zebrafish heart. (B)
Trichrome stained histological section through the ventricle and bulbus arteriosus, which labels myocardium in
red whereas nonmuscle tissue and extracellular matrix in blue. Note the trabecular layer, which is extensive in
the adult zebrafish heart, while the compact layer makes only a minor fractor of the total mass of the ventricular
wall. Rarely coronary vessels are observed in the compact layer mocardium.
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epithelial–mesenchymal transition (EMT) proceeds into the larval stages of development and is
completed by 16 dpf.39 In amniotes, endocardial cells also participate in septum formation in the atria,
ventricles and outflow tract (OFT). The significance of proper valve formation, illustrated in congenital
valve defects and adult onset congenital valve disease (CVD), renders it one of the most extensively
studied aspects of heart development. Studies in vertebrate embryos and in vitro with the help of EMT
collagen gel assays have demonstrated the involvement of multiple signaling pathways, including
VEGF,40 Notch,41,42 ErbB,43,44 Bmp,45,46 TGFb,47 Wnt48 and NFAT49 (for reviews50,51).
Zebrafish mutants with defective heart valves usually display symptoms of blood regurgitation,
which is used as an indicator in a forward genetic screen for valvular defects.52 The importance of
extracellular matrix, heparan sulfate proteoglycan production, in valve specification is highlighted in
the Jekyll mutant that encodes UDP-glucose dehydrogenase,35 which has also been recently linked to
CVD in humans.53 Another ECM protein, nephronectin, regulates AV valve differentiation acting through
a Bmp4-Has2 pathway.54 In addition, zebrafish mutants defective in WNT signaling pathway
components – axin (mbl), adenomatous polyposis coli (apc) and glycogen synthase kinase 3 (gsk3)
do not form proper valves.48–55
The endocardium, which is connected to the vasculature, is constantly exposed to hemodynamic
forces. Experimental changes of cardiac hemodynamics have a strong impact on the formation and
growth of the valve leaflets.52 With the help of high speed video imaging and blood flow pattern
analysis, Vermot et al. demonstrated recently the requirement of reverse blood flow in patterning the
atrioventricular valve in addition to the identification of endothelium-derived klf2a acting as a sensor of
hemodynamic force and possibly as an indicator of defective valve formation.56 Blood flow also has its
impact on cardiac trabeculation, myocyte growth and chamber maturation, most likely via the
endocardium.57–59
In the mature heart two valves are present, the atrioventricular (AV) and the bulboventricular (BV)
valves (Fig. 1).60 Some significant morphological differences exist between the valvular apparatus in
fish and the mammalian heart. For example, the AV valve lacks papillary muscles and chordae
tendinae. Moreover, the BV valve, homologous to the aortic valve, has only two leaflets instead of
three, which is found in the mammalian heart.60 The outflow tract in the zebrafish also shows a
significant divergence form the mammalian heart in that is has an additional chamber-like structure,
the bulbus arteriosus (BA), which is highly distensible due to the presence of large amounts of elastic
fibers (Fig. 1). The BA is believed to be a vascular adaptation, which is required to accommodate the
short distance between the BA and the gill apparatus and to maintain constant blood perfusion.61,62
The endocardium also plays a non-cell autonomous role in myocardial wall formation. The zebrafish
mutants heart of glass (heg), santa (san) and valentine (vtn) display a dilatation of the ventricular
chamber during early development.63,64 While the cell number is maintained, the ventricular
myocardium is unable to develop into a multilayered wall. As a consequence, the chambers are
massively dilated and dysfunctional. Heg1, which is the gene mutated in heart of glass, encodes a
transmembrane protein that directly associates with the proteins Ccm1 and Ccm2, which are defective
in the santa and valentine mutants and also display ventricular dilatation due to insufficient wall
formation.64,65 CCM1, CCM2 and CCM3 have been genetically linked to a common neurological disease,
cerebral cavernous malformation, which causes a dilatation of blood vessels in the brain and ultimately
causes cerebral hemorrhage.65 The CCM proteins form with Heg1 a plasma membrane-associated
complex that affects endothelial cell-cell-interaction through the modulation of the actin
cytoskeleton.66 Presently, it is unclear how defective endocardial cell-cell interaction affects
ventricular wall formation, but secretion of an endocardium-derived signaling molecule is a likely
scenario. In the liver, the CCM complex in the vascular endothelium affects apicobasal polarity of
hepatocytes in a non-cell autonomous manner67 and it can be envisioned that a similar activity is
required at least transiently in the early heart. It will be interesting to find out whether such a signaling
pathway is still active in the adult myocardium and possibly involved in the pathogenesis of dilated
cardiomyopathy.
2.3. Secondary heart field
Recent advances in understanding heart development in mouse and chick embryos has led to the
identification of two different sources of cells that give rise to the early embryonic heart. A first heart
field lineage contributes mainly to the linear heart tube and subsequently develops into the left
ventricle, whereas the second heart field lineage develops into the right ventricle and both the outflow
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and inflow tract of the heart.68–70 The second heart field cells are located dorsal to the primitive heart
tube in the pharyngeal mesoderm. Mutants of genes that are expressed in the second heart field, such
as Isl1, are missing outflow tract, right ventricle and most of the atria.71 Interestingly, second heart field
cells also give rise to a subset of craniofacial muscles.72,73
The presence of only two non-septated heart chambers and a primitive OFT prompts the question of
the presence of the second heart field in the zebrafish. Recent work verified that there exist secondary
heart field-like cells that contribute to specific lineages of the outflow tract and distal ventricular
myocardium, which acts under latent TGFb?signaling.74 Interestingly, isl1, which is essential for second
heart field development in the mouse is dispensable for zebrafish OFT development.31
2.4. Epicardium and neural crest cells
In amniotes, epicardial cells are derived from a transient structure, the proepicardium (PE) located
adjacent to the sinus venosus at the venous pole; they migrate to the surface of the myocardium,
proliferate rapidly, and envelop most of the heart except the OFT, which is covered by epicardium from
an arterial source.75 It has been shown that morphogenetic signaling from the epicardium is necessary
for proper heart morphogenesis as well as development of coronary vasculature and cardiac
fibroblasts (reviewed in76–78). Only a few marker genes, namely wt1, tbx18 and tcf21 have been linked
to the formation of the PE and its transformation into the epicardium. As a result, the epicardium
remains the least understood cell lineage of the heart. In zebrafish, the presence of the PE and its
derivative, the epicardium, has been documented,11,79,80 but very little research has been done. This is
partly due to the lack of useful live markers. Tbx5 and Bmp signaling in PE specification, which has been
previously demonstrated both in the chicken and mouse embryo, are also essential for PE
development in the zebrafish.79 In contrast, zebrafish PE induction does not require signals from the
liver primordium as proposed in higher vertebrates.79,81 Epicardium–derived cells (EPDC) were initially
reported to also contribute to the myocardial lineage.82 However, it was subsequently demonstrated to
be due to the endogenous expression of epicardial marker genes in a subset of cardiac myocytes.83
Similarly in zebrafish, the non-epicardial expression of wt1 and tbx18 rendered these genes unsuitable
for lineage studies.84
The cardiac neural crest cells (NCC) is another extra-cardiac cell population, which in the amniote
embryo migrates into the forming pharyngeal arches and is involved in re-patterning the initially
bilaterally symmetrical pharyngeal arch arteries to form the asymmetric great arteries of the thorax.85
The NCC will form the smooth muscle tunica media of the arteries. A subpopulation of the cardiac NCC
in the caudal pharyngeal arches migrates into the cardiac outflow tract and forms the aorticopulmonary
septum dividing the common arterial outflow into the aorta and pulmonary trunk.86 A combination of
lineage tracing and ablation experiments have demonstrated Wnt-dependent contribution of cardiac
neural crest to myocardium in all regions of the embryonic fish heart87–89; this is in contrast to higher
vertebrates, where neural crest cells contribute mostly to the OFT and do not appear to invade deeply
into the developing heart tube. However, further analysis of the functional importance of the NCC in
zebrafish heart development has yet to be performed.
3. MUTANT SCREENING, TRANSGENICS AND DRUGS
In the 1990s, the first large-scale chemical mutagenesis screens using ENU in Tu¨bingen and Boston has
generated hundreds of mutants.2,3 Mark Fishman, a cardiologist who initiated the Boston screen
envisioned the strength of the zebrafish as model to study cardiovascular diseases. As described
throughout the review, many heart mutants are derived from these two screens.57
Due to a lack of embryonic stem cells in the zebrafish, targeted knockout by genetic recombination
has not been possible. Hence, the zebrafish community has been using antisense technology mainly
morpholinos, which are modified oligonucleotides that block translation or mRNA splicing leading to a
knockdown of specific genes of interest.90 However, some morpholinos can cause undesirable
nonspecific side effects such as apoptosis, edema of the fourth brain ventricle and the pericardial sac.
Careful experimental design that includes stringent controls and rescue experiments is required when
using morpholinos.91,92
Regardless, the effect of morpholinos is short-lived and therefore analysis of gene function is
confined to the embryonic and early larval stages. Attempts to generate mutants include targeting
induced local lesions in genomes (TILLING) and insertional mutagenesis. Tilling is slow and tedious,
however it has generated a significant number of mutations in important genes.93 Insertional
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mutagenesis, which aims to create mutants by insertion of a foreign DNA into the zebrafish genome,
has been carried out using a number of different constructs with varying results. Large-scale screens
were performed with a mouse retroviral vector94 and transposons. Tol2 transposon95,96 and the
sleeping beauty transposon97 have been used in enhancer and gene trap screenings. The use of Tol2
transposon to mutagenize genes has not been successful, but hundreds of transgenic marker lines
have been produced instead that serve as markers for studying various biological process or organ
structures (Fig. 2).11,95,98 A promising novel approach involves the use of an in vivo protein-trap
mutagenesis system, which can be used to assess spatiotemporal protein expression dynamics and
gene function.99
Figure 2. Transgenic labeling of tissues and cell types in the zebrafish heart using GFP reporter genes. (A) The
different cell types of the zebrafish heart are GFP-labeled by transposon mediated insertional transgenesis. (A)
Schematic depiction of a zebrafish heart indicating the route of blood flow from the sinus venous, through the
atrium, ventricle and exiting from the bulbus arteriosus. GFP expression present in the three cardiac layers - (B,E)
endocardium, (C) myocardium and (D, F) epicardium as well as examples of transgenes with a region-specific
expression pattern including the (G) ventricle, (H) atrium, (I) bulbus arteriosus and (J-L) valves. Expression
patterns are shown in the (B-D, I) embryonic, or (E-F,J-L) adult heart. Abbreviations: A, atrium; AV, atrioventricular
valve; BA, bulbus arteriosus; BV, bulboventricular valve; V, ventricle. From11 with permission.
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The plan to saturate the zebrafish genome or to generate a mutant for every gene is becoming
possible with the arrival of zinc-finger based mutagenesis tools - zinc finger technology100 and TALEN
(transcription activator-like effector nucleases).101 Zinc-finger nucleases (ZFNs) induce a targeted
double-strand break in the genome that is repaired to generate small insertions and deletions.102 The
major drawback for the use of ZFNs is the cost involved and the requirement of laborious screening
efforts. TALEN however seems to be a technology with potential to become the method of choice in
creating mutants of any gene of interest. TALEN proteins have a simpler mode of DNA base recognition
than zinc fingers, with an individual base recognized by only two amino acids in an individual TALE
repeat unit.101 Due to this property, gene-specific TALENs are rapidly assembled even for small
laboratories, thus making it likely that this technology will find wide distribution. Initial reports suggest
that mutagenized genes are germline transmitted, and therefore novel mutant lines are rapidly and
efficiently produced.103 A recent report suggests that not only indel mutations are possible but also
site-directed integration of loxP sites, which is a prerequisite for Cre-mediated conditional
mutagenesis. Likewise, the DNA repair following TALEN nuclease treatment can also be modified so
that single point mutations can be introduced in any gene, which will be useful to model gene
mutations associated with cardiovascular disease in the zebrafish model.104
Another important area, in which the zebrafish model may find its use, is chemical genetics, i.e. the
search for novel cardiovascular drugs.105 The zebrafish larvae can be kept in 384 well plates and
chemical compounds are directly added to its aquatic environment, and are, therefore, readily
absorbed avoiding the need for time-consuming injections. Zebrafish embryos can be maintained for a
few days in 96-well plates with several embryos per well or singly in 384 well plates. Compounds can
be added and the plates can be screened either by eye or with the help of high-throughput video
techniques. Numerous chemical libraries exist, from small collections of characterized compounds to
larger libraries consisting of tens of thousands of compounds of uncharacterized function. In a recent
report, larval zebrafish were used to screen chemical compounds that modulate heart failure-specific
gene expression patterns.106 The authors made use of the promoter of the zebrafish nppb gene, which
appears to respond to pathological signaling pathways in a very similar way as in mammals. The long
QT (LQT) phenotype, which develops in the zebrafish kcnh2 mutant, was utilized in a large-scale
screening approach to search for chemical compounds with a LQT suppressive ability.107 A screen for
molecules that enhances FGF signaling resulted in the identification of a novel compound, which
increased the size of the embryonic zebrafish heart.108 This compound may have the potential to
enhance cardiac regeneration in vivo or to improve the efficiency of generating cardiac myocytes from
stem cell cultures. These few examples demonstrate the power of the zebrafish model for chemical
genetic approaches.
4. CARDIAC CONDUCTION SYSTEM (CCS)
Even with only a two-chambered heart, a functional CCS is necessary to initiate, maintain and
coordinate heart rhythm so that synchronized contraction can take place. A large-scale screen for gene
mutations affecting the CCS was recently conducted which helped to define four stages of CCS
development in zebrafish and furthermore lead to the identification of 17 mutants with defects in one of
these stages.109 Stage 1 occurs between 20–24 hpf, when a linear activation wave travels across the
heart tube from the sinus venosus to the OFT; in stage 2 (36–48 hpf), a significant AV conduction delay
develops; in stage 3 (72–96 hpf), an immature fast conduction network develops within the ventricle;
and in stage 4, this fast conduction network fully matures resulting in appearance of an apex-to-base
activation pattern.109
The presence of the pacemaker in zebrafish had been enigmatic for many years with only two
publications describing a mutant, slow mo, with defective pacemaker current.110,111 However,
pacemaker activity is clearly present in fishes and its function is similar to that of mammals.112 By
recording action potentials from the hearts of a variety of fishes, Saito (1969) concluded that the
pacemaker site is at the sinoatrial valve.113 Consistent with this, a recent study showed that knockdown
of shox2 resulted in pronounced sinus bradycardia.114 Finally, with a combination of optogenetics,
which utilizes transgenic expression of light-controlled ion channels and light sheet microscopy, the
cardiac pacemaker of the zebrafish has been localized to a few cells in the sinoatrial region.115 The Isl1
genes in zebrafish, human and mouse heart is expressed in sinoatrial pacemaker cells.116 While in
mammals Isl1 labels a subset of sinoatrial node cells, in zebrafish, isl1 expression demarcates the
entire pacemaker population, which forms a ring-like structure at the border between the sinus
Page 15 of 28
Poon and Brand. Global Cardiology Science and Practice 2013:4
venosus and the atrium.116 The isl1-positive cells also express tbx2b and are characterized by the
presence of primitive action with a pacemaker potential.
The AV conduction system is responsible for delaying the electrical impulse between the chambers
so as to achieve coordinated contractions. By calcium mapping with calcium green dyes, a retardation
of calcium waves at the AV junction is observed at 40 hpf in the zebrafish. Interestingly, the
specification of zebrafish AV conduction is mediated by the endocardial signals notch1b and
neuregulin.117 In addition, foxn4, which drives the expression of tbx2b, is involved in AV canal
specification and mutants of both genes display AV conduction defects.36 Recently, one member of the
Popeye domain containing gene family, popdc2 has been shown to exhibit AV conduction
abnormalities, which reflects its role in the regulation of the cardiac conduction system (Fig. 3).118
The apex-to-base ventricular activation in both embryonic and adult zebrafish has been optically
mapped by individual groups.109,119 This electrical activity is most likely transmitted by the gap junction
protein Cx40, which immunoreactivity has been detected in the embryo at 4 dpf, supporting the
presence of a fast CCS at this stage in development.109 In the absence of morphologically defined
His-Purkinje bundles in zebrafish, it has been proposed that the impulse travels through ventricular
trabeculae, which are the evolutionary precursors of Purkinje fibers in amniotes. In fact, the CCS does
not mature in a mutant that is devoid of trabeculae.30 Studies in embryonic zebrafish with an aberrant
cardiac conduction revealed the importance of cardiac conduction in influencing chamber
morphogenesis.120 The authors furthermore uncovered a novel connexin gene, cx46, in conduction
of electrical impulse which results in CCS defects in mutant mouse that resemble human heart
failure patients.
Figure 3. Analysis of cardiac arrhythmias in zebrafish popdc2morphants. (A) Ventricular contractions are regular
in control animals (CTR) but display 2:1 and 3:1 secondary AV block in popdc2 morphants (MO1). (B, C) Optical
mapping of calcium waves in control and morphant hearts reveal aberrant calcium waves in Popdc2 morphants.
From111 with permission.
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5. CARDIAC ELECTROPHYSIOLOGY
Despite the small size of the zebrafish embryonic heart (100–150mm), an electrocardiogram (ECG)
of the zebrafish heart can be recorded using micropipette electrodes from as early as 5 dpf with
apparent P and R waves that reflect atrial and ventricular depolarization, respectively.121 As the larvae
develop further and the heart matures, the ECG pattern changes accordingly with the emergence of
T waves at 2 weeks post fertilization followed by the shortening of QRS interval and finally distinct P
waves, QRS complexes, and T waves, which are detectable by 35 dpf.122,123 The surprisingly close
resemblance of the zebrafish ECG morphology to that of the human heart probably reflects the crucial
importance of electrical activity for governing the heartbeat and is therefore evolutionary conserved.
The relative simple design of the zebrafish heart, containing only the essential elements of the
cardiac conduction system, offers an advantage to study fundamental questions of cardiac
electrophysiology.
The fish heart beats at a rate of 120–180 beats per minute (bpm), which is closer to the human heart
rate (60–100 bpm) than the mouse (300–600 bpm). As a result, the cardiac repolarization phase, a
diagnostic feature for possible arrhythmias represented by the length of the corrected QT (QTc) interval,
is more similar between human (300–450 msec) and zebrafish (300–440 msec), than mouse (83–96
msec).124,125 Furthermore, both the human and the zebrafish generate a repolarizing current during the
cardiac action potential (AP) using a similar rapidly activating delayed rectifier potassium current (IKr),
which is in contrast to the mouse that uses a different set of potassium channels.126 The similarity in
cardiac repolarization between humans and mice is also evident in the phenotypes of the breakdance
and reggae mutants, which are defective in the ERG potassium channel and exhibiting either long QT
syndrome or short QT syndrome.127– 129 In fact, QT syndrome mutations have been successfully
modeled in the zebrafish but not in mice.125
Specific ion channels, mainly gating sodium, potassium and/or calcium ions generate unique
currents that shape the different phases of the cardiac AP. Knowledge of the set of ion channels that
contribute to the zebrafish cardiac AP are derived from fish mutants defective in ion channels as well as
with the help of pharmacological experiments.126 By detailed comparison of the AP between human,
mouse and zebrafish cardiac myocytes, it was found that the AP parameters - AP amplitude and the
resting membrane potential were highly similar between zebrafish and humans, whereas the fish has a
lower maximum depolarization velocity (dV/dtmax) (Fig. 4). This is possibly due to less competent or
fewer fast sodium channel that drives INA. The AP profile of both atrial and ventricular adult zebrafish
cardiac myocytes are comparable to that of the humans, especially the long plateau phase 2 and the
resulting action potential duration (APD) except for the lack of the sharp early repolarization phase 1,
which is probably due to a non-functional Iks current in zebrafish cardiac myocytes.
119 Sodium channels
blocker (tetrodotoxin, TTX) decelerate the AP upstroke velocity confirming the role of INA in establishing
the steep slope of the rapid depolarization phase 0 of the AP. Interestingly zebrafish cardiac myocytes
are 10–100x more sensitive to TTX than mammalian cardiac myocytes due to the presence of an
aromatic amino acid at a critical position, which is thought to increase the TTX sensitivity.130 The L-type
calcium channel (LTCC) contributes to the AP plateau phase indicated by the result that LTCC blocker,
nifedipine, shortens both atrial and ventricular AP. Moreover, the LTCC mutant island beat embryos
exhibit an absence of the QRS complex causing atrial fibrillation and a silent ventricle.131 Unexpectedly,
apart from LTCC, functional T-type calcium channel (TTCC) also contribute to the calcium current in
adult zebrafish cardiac myocytes,126 which can be considered as an indication of an immature state of
the adult zebrafish heart in comparison to mammals, where the TTCC is only present in the embryonic
heart and in pacemaker tissue.
Although this has not yet been confirmed, the zebrafish heart most likely employs a similar
pacemaking mechanism as mammals and probably depends on the activity of the hyperpolarization-
activated cyclic nucleotide-gated channel. Unfortunately, the slow mo mutation, which has a defective
pacemaker current, has not been molecularly characterized until now.110,111
In terms of establishing ion homeostasis, cardiac myocytes utilize the sodium/calcium exchanger
(Ncx1) and calcium ATPase at the plasma membrane (PMCA) and sarcoplasmic reticulum (SERCA) to
regulate the cytosolic calcium concentration and the Na/K-ATPase for maintaining a proper
sodium/potassium gradient. The mouse Ncx1 mutant is embryonic lethal due to a vascular function of
the Ncx1 gene whereas a cardiac-specific Ncx1 null mutant reaches adulthood with cardiac myocytes
exhibiting normal calcium transients.132,133 In contrast, the cardiac-specific ncx1 mutant (tremblor, tre)
displays atrial fibrillation and arrhythmia whereas the ventricle is noncontractile due to calcium
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overload.134,135 The difference in phenotype severity of the mutants is most likely based on differences
in the calcium homeostasis and genetic buffering mechanisms in these species.
One interesting observation is that some channel proteins do have non-electrical related functions in
early embryonic development. The heart and mind (had), which is defective in the Na/K-ATPase a1B1
isoform, causes severe abnormalities in primitive heart tube extension, cardiac myocyte differentiation
and compromised cardiac function. These phenotypic anomalies are found to be direct consequences
of defective pump activity resulting in ionic imbalances that affect the maintenance of proper
myocardial cell junctions in the early embryonic heart.136,137 The morpholino-mediated knockdown of
the voltage-gated sodium channel scn5a caused a reduction in the expression of the cardiac
transcription factors and had an negative impact on proliferation and differentiation of cardiac myocyte
resulting in abnormal cardiac morphogenesis.138 These phenotypes were not reproduced by the
administration of TTX, suggesting a novel non-electrogenic function of scn5a.
6. CARDIOMYOPATHY
Zebrafish has an established track record in uncovering the molecular mechanisms of human
cardiovascular diseases (CVD), which includes prevalent forms of cardiomyopathy - dilated
cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). It was observed that some mutants,
generated from forward genetic screens, exhibit a lack of blood circulation together with pericardial
edema. By high-speed video imaging of the embryonic heart, standard non-invasive assessments of
cardiac performance were made and revealed compromised cardiac contractility, shortening fraction
Figure 4. Atrial and ventricular action potentials in the zebrafish, human and mouse. Representative shapes of
action potentials in (A) zebrafish, (B) human, and (C) mouse. Note the similarity between the ventricular action
potentials in humans and zebrafish. From119 with permission.
Page 18 of 28
Poon and Brand. Global Cardiology Science and Practice 2013:4
(sometimes presented in M mode), stroke volume and/or cardiac output. Positional cloning of these
mutants showed that many of the mutated genes were cardiac sarcomeric genes, which have been
previously implicated in human cardiomyopathy such as titin (ttn),139 tropomyosin (tpm4),140 troponin
2 (tnnt2),141 myosin light chain genes (cmlc1, myl7)142– 144 and myosin heavy chain (myh6).145
Moreover, these mutants also exhibit myofibrillar disarray, one of the hallmarks of cardiomyopathy as
revealed by ultrastructural examination of sarcomeric organization.146
Cardiac myofibrillogenesis in the zebrafish has been characterized but not completely understood.
Non-striated actin filaments are the first to assemble at the plasma membrane. Sarcomeric myosin
independently assembles into thick filaments before being integrated into the thin filament network.25
Next, M-lines of fixed width and Z-discs, which elongate from Z bodies, are recruited to the contractile
units. Phenotypic differences of different mutations of sarcomeric genes also provide an opportunity to
understand their unique and specific roles in myofibrillogenesis. This becomes apparent in the case of
titin isoforms and has also been observed for the alkali and regulatory myosin light chains, which have
distinct roles in the process of myofibril assembly.143,147 The zebrafish is also instrumental to unravel
the function of novel myofibrillar genes. Kindlin2, an integrin-binding protein first identified in
Caenorhabditis elegans localizes to the intercalated disc. Morpholino-mediated knockdown abolishes
sarcomere assembly at the plasma membrane and causes contractile dysfunction.148,149 Myozap,
another intercalated disc protein, which directly interacts with desmoplakin and zonula occludens-1
participates in the Rho-signaling pathway and activates serum response factor dependent
transcription.150 Consistent with its role in myofibrillar-nuclear communication is the fact that the
knockdown of Myozap in zebrafish causes a severe cardiomyopathy-like phenotype. Chap is another
newly identified Z-Disks proteins and the loss-of-function phenotype includes severely impaired heart
function.151
The efficient and cost-effective zebrafish system is also used to study the physiological roles of
mutations found in patients with heart failure such as in TNNT2146 and especially non-sarcomeric
genes, including transcriptional coactivator EYA4152 and RNA-binding protein RBM24 (Fig. 5).153 Cardiac
myosin light chain kinase (mlck) was identified in a microarray comparison of healthy and failing
human hearts. Its crucial role in cardiac function is suggested by its morphants, which develop a
dilated cardiac ventricle with immature sarcomere organization.154 Nexilin, a novel Z disk protein,
functions to stabilize the Z-disks in zebrafish and is a candidate in causing DCM in patients.155
Interestingly, more evidence has substantiated the effect of cardiac mechanical stretch sensing on
regulation of heart function hence resulting in cardiomyopathy. In zebrafish, the first clue comes from
the positional cloning of the contractility-deficient mutant main squeeze (msq), which fails to express
stretch-responsive genes.156 The extracellular matrix protein integrin-linked kinase (ilk) is mutated in
msq. ILK, found to localize to Z-Disks interacts with integrin and b-parvin together with many other
proteins forming a complex at the cell membrane, which acts as a mechanosensor and signals into
cardiac myocytes. PINCH, which is also part of the mechanosensor complex, has been shown to
regulate contraction in the zebrafish heart.157 More importantly, human patients with DCM were also
found to bear mutations in ILK or laminin-alpha4 (Lama4), yet another of ILK interaction partner.156,158
Collectively, these genetic and biochemistry data emphasize the importance of the mechanosensor
Figure 5. Contractile dysfunction in the zebrafish heart. Morpholino-mediated knockdownn of the gene encoding
the RNA-binding protein Rbm24a causes contractile dysfunction as evidenced by M mode analysis (left panels)
which shows significant difference between end-diastolic (Dd) and end-systolic (Sd) diameter of the rbm24a
morphant (lower panel) as compared to control embryo (upper panel). Furthermore, sarcomeric defects are
observed in the thin filament (visualized by anti-Tnnt2 immunohistochemistry) and Z-Disc (visualized by anti-a-
Actinin immunohistochemistry) that most likely cause the contractile dysfunction. From146 with permission.
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complex in the regulation of cardiac function. In addition, a M-band protein, myomasp
(Myosin-interacting, M-band-associated stress-responsive protein) has been shown to regulate stretch
responsive genes and hence cardiac stretch sensing via an alternative pathway that involves serum
response factor (SRF)-dependent signaling.159 To investigate myocardial function in greater detail, the
micromechanical properties of zebrafish myofibril has been evaluated and proven to be a feasible
contractile model where functional studies at subcellular level can be carried out.160 This might serve
as another step forward in reaching a detailed molecular understanding of the etiology of
cardiomyopathy. On another note, Werdich et al. tested the stretch response of embryonic zebrafish
heart exploring the feasibility of using the zebrafish as novel model to study the mechano-electrical
feedback of the heart.161
One main limitation of the zebrafish embryonic models of cardiomyopathy is that it does not go
through the progressive stages of cardiac remodeling as in patients due to the fact that so far most of
the studies utilized zebrafish embryos or larvae. Hence, developing an adult cardiomyopathy model in
zebrafish, which more closely mimics the human pathological process would be an important
improvement. Recently, two adult models of cardiomyopathy have indeed been developed. The first is
anemia-induced either by a band3 mutant that inflicts chronic stress in the heart or through the use of
the anemia-inducing drug phenylhydrazine.162 Encouragingly, the mutant hearts displayed myocyte
hypertrophy and hyperplasia as well as several features of human cardiomyopathy, comprising
myocyte disarray, fetal gene expression reactivation, and severe arrhythmia. The second model was
generated by cardiomyopathy-inducing doxorubicin (DOX) injection.163 These two zebrafish
cardiomyopathy models used in combination with a target of rapamycin (ztor) mutant fish, served to
provide genetic evidence for a cardioprotective function of target of rapamycin (TOR) signaling.
7. HEART REGENERATION
The zebrafish heart demonstrates the surprising capability of myocardial regeneration within months
after experimental induction of myocardial injury. Experimental procedures to induce myocardial
regeneration include 20% ventricular resection,164,165 or cryocautherization, which induces localized
injury of 25% of myocardium166,167 or diphtheria toxin A chain (DTA)-induced cytoxicity that kills up to
60% of cardiac myocyte.168 Apart from demonstrating a similar capacity for cardiac regeneration in
neonatal mice,169 this trait of regeneration is absent or possibly turned off in adult mammals. This
prompted the zebrafish to become the key model for elucidating the molecular machinery of heart
regeneration, which would fuel the development of regenerative medicine for human cardiovascular
diseases. Newts and some other lower vertebrates also exhibit a similar level of cardiac regenerative
capability170,171 but are not as favorable to work on due to practical reasons relating to the lack of
genetic infrastructure and tools as compared to the zebrafish model.
Within hours of ventricular resection, the endocardium undergoes extensive changes in morphology
and gene expression, most notably the upregulation of raldh2, which is a key enzyme, involved in the
synthesis of retinoic acid (RA) and promotes cardiac myocyte proliferation.172 The stimulation and
prolongation of retinoic acid signaling is supported by epicardial cells and it is thought that these
combined efforts of the endocardium and epicardium, may serve as the major trigger of cardiac
myocyte proliferation.
The activated epicardial cells (3 days post amputation) invade the wound site in the zebrafish heart
and give rise to coronary vessels via epithelial–mesenchymal transition (EMT), regulated by snail2 and
twist1b.173 This process is reminiscent of coronary arteriogenesis during embryonic heart development,
which is regulated by FGF and PDGF signaling.174–176 FGFRs ( fgfr2 and fgfr4) in the epicardial cells
respond to their ligand, fgf17b, which is transcribed in the myocardium, to promote epicardial EMT and
further neovascularisation.173 This process when inhibited will results in a block in regeneration. A hint
for an involvement of PDGF signaling stems from an earlier transcriptome analysis of regenerated heart
tissues, which identified an upregulation of pdgfa.177 Blocking PDGF using an inhibitor demonstrates
the requirement of epicardial-derived pdgfrb for epicardial proliferation and coronary vessel formation.
In experiments where zebrafish epicardial cells are cultured on fibrin gel in vitro, PDGF is found to
induce stress fiber formation and loss of cell–cell contacts, mediated by Rho-associated protein
kinase, ROCK.178 Cardiac revascularization, inherent to the zebrafish, may account for the difference in
regeneration abilities, between fish and mammals. Therefore, elucidation of the process of epicardial
EMT and subsequent neovascularisation may help to shed light on new developments for regenerative
medicine.
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The origin of the new myocardium that replaced the injured myocardium has been a case of
speculation and epicardial cells with their ability to undergo cell type switch is suspected of
contributing to new myocardium. However, the studies described above indicate that the epicardium
does not contribute to new cardiac myocytes, but instead serves as a source of coronary vasculature,
which is essential for the growth of new cardiac myocytes. Most recently, Kikuchi et al. confirmed that
tcf21positive epicardial cells are restricted to non-myocardial cell fates by Cre-based fate-mapping
experiments.84
The quest for the origin of new myocardium has lead to several genetic cell lineage studies that
finally revealed that the source is not cardiac progenitors but pre-existing cardiac myocytes.179,180 In
response to injury, these cardiac myocytes undergo dedifferentiation and is accompanied by
sarcomeric disassembly and aberrant electrical phenotypes including a reduction in conduction
velocity and breaking of the depolarization wavefront, which are signs of functional uncoupling of
cardiac myocytes. Dedifferentiated cardiac myocytes can then re-enter the cell cycle and proliferate to
supply new functional cardiac myocytes. This intriguing finding suggests the possibility of harnessing
the potential of pre-existing cardiac myocytes in failing human hearts.
Cardiac myocyte proliferation is thus an important step, and if blocked, as in the cell cycle mutants
mitotic checkpoint kinase (mps1) and polo-like kinase 1 (plk1)181,182 or by overexpression of the
microRNA miR-133,183 cardiac regeneration is retarded. miR-133 is one of the microRNAs, which is
downregulated during the course of cardiac regeneration. Similarly, if injured zebrafish heart is blocked
from entering into the cell cycle by activating the well-known mammalian cell cycle inhibitors p38a
MAPK, the ability of cardiac regeneration is compromised.182 It is exciting to note that the zebrafish
heart employs similar molecular mechanisms for the regulation of cardiac myocyte proliferation as in
mammals, substantiating the relevance of the zebrafish model to develop regenerative therapies for
the human heart.
Recently, the question of how proliferating cardiac myocytes actually reach the wounded
myocardium was addressed. Expression screening using the regenerating zebrafish heart identified the
genes cxcl12a, encoding a chemokine ligand (also known as sdfa1), and its receptor cxcrb4 to be
expressed during heart regeneration.184 The CXCL12-CXCR4 system is known to regulate directed cell
migration during embryonic development.185 Interestingly, cxcrb4 was expressed in proliferating
cardiac myocytes, while the ligand was found in activated epicardium. Loss-of-function experiments
clearly demonstrated that blocking Cxcr4 function only affects the migration of proliferating cardiac
myocytes to the wounded area, while other aspects like the level of cell proliferation or gene
expression were not affected. Thus an epicardium-mediated guidance of proliferating cardiac myocytes
via CXCL12-CXCR4 signaling to the wounded area is essential for zebrafish heart regeneration.
As mentioned earlier, cryoinjury was also applied as technique to cause damage to zebrafish cardiac
cells.166,186 This method appears to be superior to ventricular resection, since it better resembles
myocardial infarction in patients, which is characterized by irreversible replacement of damaged
myocardium by a fibrotic collagenous scar that lacks the functional contractile properties of healthy
myocardial cells. Despite scar formation, the teleost is able to rapidly regenerate its injured heart by
elimination of the scar through apoptosis and triggering proliferation of cardiac myocytes. In fact, it has
been recognized that transient scar formation is advantageous for cardiac regeneration serving as a
transitional support required by the dynamic beating heart, before being removed and the space is
populated by cardiac myocytes.187 Chablais and Jaz´win´ska further elucidated that Smad3-dependent
TGFb/activin signaling mediates multiple important steps: inflammatory response of infiltrating
immune cells during cardiac cells apoptosis; ECM production by fibrotic cells to form scar and
subsequent cardiac myocyte proliferation. The coordination of this highly complex process remains to
be clarified.
In a short span of ten years since the discovery of the regenerative potential of the zebrafish heart,
our understanding of this process has greatly advanced and further research promises more answers
and mechanistic insights into the amazing property of the zebrafish heart, which potentially will also
lead to novel therapeutic options to treat heart failure patients.
8. FUTURE PROSPECTS
The zebrafish has seen a surprisingly rapid and extremely successful career as a model organism in
cardiovascular research. As an affordable in vivo model, the zebrafish will continue to be used to
assess candidate genes (from microarray or genome wide association studies) that may have a cardiac
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phenotype. There are only a few areas in cardiovascular research in which the potential of the zebrafish
model has not yet been tested. The challenge for the zebrafish community will be to model human
cardiovascular pathology in this organism even closer than it is now. Recent technical improvements
allow the generation of mutants for any gene. Thus it is likely that in the not too far future, mutants for
nearly every gene will be available. Genetic interactions between genes, gene-environment
interactions, or the role of modifier genes, which are important determinants of the phenotype severity
of a particular mutation, can be analyzed at ease and with significant lower costs than in mice. There is
exciting progress in the increasingly sophisticated means of genetic manipulation in zebrafish that
parallels that of mice. Certainly the zebrafish will not be able to fully substitute the mouse, however it
will reduce the number of experiments that need to be performed in mammals. Moreover, recent
improvements in mass screening approaches such as chemical genetics will be a prime area for the
zebrafish model. In conclusion, with well-constructed thoughtful experimental designs, a bright future
is assured for the small but mighty zebrafish model.
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